AU3629999A - [2-alkyl-5-halogeno-6-(4-trifluoromethylphenyl)-4-pyrimidiny amino]acetamide derivatives, process for producing the same, medicinal composition containing the same, and intermediates for the compounds - Google Patents

[2-alkyl-5-halogeno-6-(4-trifluoromethylphenyl)-4-pyrimidiny amino]acetamide derivatives, process for producing the same, medicinal composition containing the same, and intermediates for the compounds

Info

Publication number
AU3629999A
AU3629999A AU36299/99A AU3629999A AU3629999A AU 3629999 A AU3629999 A AU 3629999A AU 36299/99 A AU36299/99 A AU 36299/99A AU 3629999 A AU3629999 A AU 3629999A AU 3629999 A AU3629999 A AU 3629999A
Authority
AU
Australia
Prior art keywords
same
pyrimidiny
halogeno
trifluoromethylphenyl
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36299/99A
Inventor
Mari Itoh
Teruya Murata
Kazunori Ohno
Masayasu Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of AU3629999A publication Critical patent/AU3629999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU36299/99A 1998-05-18 1999-05-11 [2-alkyl-5-halogeno-6-(4-trifluoromethylphenyl)-4-pyrimidiny amino]acetamide derivatives, process for producing the same, medicinal composition containing the same, and intermediates for the compounds Abandoned AU3629999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15377698A JP2002241369A (en) 1998-05-18 1998-05-18 4-pyrimidinylaminoacetamide derivative and pharmaceutical composition containing the same
JP10/153776 1998-05-18
PCT/JP1999/002415 WO1999059980A1 (en) 1998-05-18 1999-05-11 [2-alkyl-5-halogeno-6-(4-trifluoromethylphenyl)-4-pyrimidinylamino]acetamide derivatives, process for producing the same, medicinal composition containing the same, and intermediates for the compounds

Publications (1)

Publication Number Publication Date
AU3629999A true AU3629999A (en) 1999-12-06

Family

ID=15569897

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36299/99A Abandoned AU3629999A (en) 1998-05-18 1999-05-11 [2-alkyl-5-halogeno-6-(4-trifluoromethylphenyl)-4-pyrimidiny amino]acetamide derivatives, process for producing the same, medicinal composition containing the same, and intermediates for the compounds

Country Status (4)

Country Link
JP (1) JP2002241369A (en)
AR (1) AR019297A1 (en)
AU (1) AU3629999A (en)
WO (1) WO1999059980A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037916B2 (en) 1999-07-15 2006-05-02 Pharmacopeia Drug Discovery, Inc. Pyrimidine derivatives as IL-8 receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117659A (en) * 1995-04-13 2000-12-06 Dainippon Pharmaceutical Co Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
ZA977427B (en) * 1996-09-04 1998-03-02 Dainippon Pharmaceutical Co 2,4-disubstituted pyrimidine derivative, process for preparing the same, and a pharmaceutical composition containing the same.
JPH10130150A (en) * 1996-09-05 1998-05-19 Dainippon Pharmaceut Co Ltd Medicine comprising acetic acid amide derivative
TW436264B (en) * 1996-10-31 2001-05-28 Kumaii Chemical Industry Co Lt A pyrimidinyl oxyalkaneacid amide derivatives and a fungicide for agre-horticultural

Also Published As

Publication number Publication date
JP2002241369A (en) 2002-08-28
AR019297A1 (en) 2002-02-13
WO1999059980A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
AU694647B2 (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
IL174082A0 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use for the preparation of a pharmaceutical composition
HUP0002893A3 (en) Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
AU1231697A (en) Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
AU9002598A (en) Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
HUP0101375A3 (en) Novel cephalotaxane derivatives, process for their preparation and intermediates
AU3031797A (en) New substituted 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them
AU8562898A (en) Thienopyridine derivatives, intermediates thereof, and process for producing theboth
AU6062498A (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
AU5426500A (en) Benzazepine derivatives, process for the preparation of the same and uses thereof
AU6123099A (en) Process for the preparation of amine derivatives
AU7972200A (en) Process for the preparation of urea
AU2466700A (en) Process for the preparation of urea
AU1354199A (en) Process for the preparation of urea
AU4071095A (en) Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition
AU5881499A (en) Process for the preparation of corroles and several such new compounds, including chiral derivatives, and the use thereof
HU9602763D0 (en) Novel isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
AU4659199A (en) Process for the preparation of urea
AU4913399A (en) Thioazepinone derivatives, preparation method and intermediates therefor, use asmedicines and pharmaceutical compositions containing same
AU3851899A (en) Novel substituted guanidine derivatives and process for producing the same
HUP0003766A3 (en) Isoguinolin derivatives, process for producing them and pharmaceutical compositions containing them
HU9800472D0 (en) New benzoxazinedion derivatives, process for producing them and use of them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase